🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3b study is being conducted for the purpose of registration of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-10-01
Trial ID
NCT00751348
Treatments Being Tested
The study was designed to evaluate whether the first CYD dengue vaccination...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-07
Trial ID
NCT01436396
Treatments Being Tested
The current study evaluates the immunogenicity and safety in 4-6 years old ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-15
Trial ID
NCT01627561
The booster phase of the study will evaluate the safety of Hib-MenCY-TT vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07
Trial ID
NCT00345683
This study will compare three consistency lots of ProQuad to each other as ...
Status
Completed
Location
Multiple Locations
Start Date
2000-03
Trial ID
NCT00985153
This open label randomized study will be conducted to evaluate and/or descr...
Status
Completed
Location
Investigational Site Number : 3560006
Start Date
2023-03-27
Trial ID
NCT05794230
Treatments Being Tested
This Phase III, open-label, randomized, parallel-group, active-controlled, ...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-07
Trial ID
NCT03205371
Treatments Being Tested
The clinical study primarily assesses the safety of MV-CHIK a new Chikungun...
Status
Completed
Location
University of Puerto Rico - Medical Sciences Campus
Start Date
2017-08-09
Trial ID
NCT03101111
Treatments Being Tested
The purpose of this study is to evaluate end of shelf-life potency in terms...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-10
Trial ID
NCT01681992
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-03
Trial ID
NCT01777308
Treatments Being Tested